Tilray Brands Inc (2HQ.DE)

Healthcare | Drug Manufacturers Specialty Generic
Latest reporting period: 2025-11-30

Latest Quarter

2025-11-30

Revenue

$304M

Net Income

-$62.8M

Operating Margin

-10.2%

Free Cash Flow

-$175M

Debt / Assets

29.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Tilray Brands Inc (2HQ.DE).
Income Statement (Quarterly) 2025-11-30 2025-08-31 2025-05-31 2025-02-28
Revenue 303,852,928 287,778,953 308,104,681 268,340,631
Cost of Revenue 223,530,769 208,837,236 215,299,355 193,215,943
Gross Profit 80,322,159 78,941,717 92,805,326 75,124,688
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 102,078,725 88,423,954 81,724,892 86,874,882
Operating Expenses 111,445,476 76,068,062 2,074,228,475 1,172,769,024
Operating Income -31,123,317 2,873,654 -1,981,423,149 -1,097,644,336
Interest Expense 7,507,370 9,197,893 5,442,105 12,101,183
Income Before Tax -55,827,511 -1,060,450 -1,911,511,441 -1,144,442,896
Income Tax Expense 4,953,691 -3,138,767 -171,718,600 1,737,613
Net Income -62,767,708 -442,312 -1,746,516,571 -1,140,261,358
Per Share
EPS -0.41 0.00 -17.80 -12.60
EPS Diluted 0.00 0.00 0.00 0.00